MannKind Corp
MNKD
$4.14
Share price
0.85%
Change (1 day)
1.10%
Change (1 year)
Categories
MannKind Corp (MNKD) Fails to deliver data
Key failure to deliver metrics for MannKind Corp:
- Last SEC data release: 2023-08-14
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $1.32 M
- Last year FTD volume: $17.66 M
Failures to deliver for MannKind Corp (MNKD) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for MannKind Corp (MNKD) - since 2017
Volume in USD (price x number of shares), data since 2017MannKind Corp (MNKD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $7.37 M | -66.49% |
| 2022 | $22.01 M | 1.48% |
| 2021 | $21.69 M | 179.74% |
| 2020 | $7.75 M | -36.36% |
| 2019 | $12.18 M | -71.71% |
| 2018 | $43.07 M | -70.36% |
| 2017 | $0.14 B |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $39.54 M | $0.40 B | 🇺🇸 USA |
 Novo Nordisk NVO | $19.96 M | $59.05 M | 🇩🇰 Denmark |
 Eli Lilly LLY | $20.9 M | $0.18 B | 🇺🇸 USA |
 Merck MRK | $0.10 B | $0.46 B | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $3.34 M | $38.94 M | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $5.96 M | $8.49 M | 🇺🇸 USA |